STOCKHOLM, Feb. 5, 2025 /PRNewswire/ — Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the fourth quarter 2024. Fourth Quarter 2024 Total revenue increased 9 per cent, 8 per cent at constant […]
Tag: Swedish Orphan Biovitrum AB
Bulletin from Sobi’s Extraordinary General Meeting (EGM)
STOCKHOLM, Dec. 11, 2024 /PRNewswire/ — The Swedish Orphan Biovitrum AB (publ) (Sobi®) EGM was convened today on 11 December 2024. In accordance with the Nomination Committee’s proposals, David Meek was elected as new member of […]
Sobi’s strength in haematology to be showcased at ASH 2024
STOCKHOLM, Dec. 3, 2024 /PRNewswire/ — New data from Sobi® and partners will be presented at the 66th Annual Meeting of the American Society of Hematology (ASH) in San Diego, CA (USA) from the 7th – […]
Notice of Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ)
STOCKHOLM, Nov. 11, 2024 /PRNewswire/ — The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Extraordinary General Meeting (the “Meeting“), to be held on Wednesday, 11 December 2024 […]
Notice of Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ)
STOCKHOLM, Nov. 11, 2024 /PRNewswire/ — The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Extraordinary General Meeting (the “Meeting“), to be held on Wednesday, 11 December 2024 […]
